Sequent Scientific announces acquisition of Bremer Pharma, Germany

Sequent Scientific announced that its wholly owned subsidiary Alivira Animal Health through Alivira Ireland, has on 17 April 2018 signed an agreement with simultaneous closing to acquire 100% of Bremer Pharma, Zydus Cadila's Animal Health Business in Germany.

Bremer Pharma, founded in 1982 is a niche veterinary health company in Germany with focus on cattle and swine segments. Bremer has a portfolio of over 400+ registered products across Europe, Far East, MENA, Russia & Africa operating in vitamins, antibiotics and hormones. Bremer registered sales of 6.7Mn ($8.3Mn) in year ending March 31, 2018 with marginal losses. Bremer comes with a EUGMP compliant injectable manufacturing facility with approval from German Competent Authority LANUV. The site was recently reinspected and obtained a renewed GMP certificate on 12 March 2018.

 

This acquisition provides Alivira's with a beta-lactam & non-beta lactam injectables facility for EU markets, which compliments its Orals & Powders beta-lactam and non-beta lactam facility based at Barcelona in Spain. EU is Alivira's largest market accounting to 60% of revenues.

Powered by Capital Market - Live News